J7530 – Mycophenolate mofetil (myhibbin), oral suspension, 5 mg

Long description

Mycophenolate mofetil (myhibbin), oral suspension, 5 mg

Short description

Mycophenolat (myhibbin) 5 mg

Pricing indicator

51 Drugs

Medicare coverage

C Carrier judgment – coverage decided by the Medicare contractor

BETOS category

O1E Other drugs

Added

October 1, 2026

Last change

October 1, 2026 – Added

Nearby J codes

• J7520 – Sirolimus, oral, 1 mg
• J7521 – Tacrolimus, granules, oral suspension, 0.1 mg
• J7524 – Mycophenolate mofetil, oral, 5 mg
• J7525 – Tacrolimus, parenteral, 5 mg
• J7526 – Injection, mycophenolate mofetil, 5 mg
• J7527 – Everolimus, oral, 0.25 mg
• J7528 – Mycophenolate mofetil, for suspension, oral, 100 mg
• J7529 – Mycophenolate mofetil, for suspension, oral, 5 mg
• J7531 – Prednisolone sodium phosphate, orally disintegrating tablet, 1 mg
• J7599 – Immunosuppressive drug, not otherwise classified
• J7601 – Ensifentrine, inhalation suspension, fda approved final product, non-compounded, administered through dme, unit dose form, 3 mg
• J7604 – Acetylcysteine, inhalation solution, compounded product, administered through dme, unit dose form, per gram
• J7605 – Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms
• J7606 – Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms
• J7607 – Levalbuterol, inhalation solution, compounded product, administered through dme, concentrated form, 0.5 mg
• J7608 – Acetylcysteine, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per gram